Cantel Medical Corp. (NYSE:CMD) Director Anthony B. Evnin bought 2,500 shares of Cantel Medical Corp. stock in a transaction that occurred on Wednesday, March 15th. The stock was bought at an average price of $77.88 per share, with a total value of $194,700.00. Following the completion of the acquisition, the director now owns 5,762 shares in the company, valued at approximately $448,744.56. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Cantel Medical Corp. (NYSE:CMD) traded down 0.53% during midday trading on Monday, reaching $78.10. The company had a trading volume of 90,177 shares. The company has a market cap of $3.24 billion, a PE ratio of 48.51 and a beta of 1.38. The company’s 50-day moving average is $80.91 and its 200 day moving average is $78.62. Cantel Medical Corp. has a 52-week low of $64.52 and a 52-week high of $88.81.

Cantel Medical Corp. (NYSE:CMD) last released its quarterly earnings results on Thursday, March 9th. The company reported $0.52 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.02. The company had revenue of $184.80 million for the quarter, compared to analyst estimates of $189.58 million. Cantel Medical Corp. had a return on equity of 17.24% and a net margin of 9.23%. The business’s quarterly revenue was up 16.7% on a year-over-year basis. On average, equities research analysts forecast that Cantel Medical Corp. will post $2.03 EPS for the current year.

Your IP Address:

Several equities research analysts recently weighed in on the company. Raymond James Financial, Inc. assumed coverage on Cantel Medical Corp. in a report on Friday. They issued a “market perform” rating for the company. Benchmark Co. boosted their target price on Cantel Medical Corp. from $83.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, December 9th.

Cantel Medical Corp. Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

5 Day Chart for NYSE:CMD

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with's FREE daily email newsletter.